FDA approves first PI3K inhibitor for breast cancer - FDA Press Releases

FDA approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine therapy fulvestrant.

from FDA Press Releases RSS Feed http://bit.ly/2W2QsKA
via IFTTT